Severity
Low
FDA Drug recall · Reported April 3, 2013
Subpotent; 12 month time point for the active ingredient Phenylephrine HCl.
L. Perrigo Co. recalled PE Daytime Cold/Flu LiqGel, Multi Symptom Relief, Acetaminophen/Dextromethorphan HBr/Phen… - a low-severity action.
PE Daytime Cold/Flu LiqGel, Multi Symptom Relief, Acetaminophen/Dextromethorphan HBr/Phen… was recalled by L. Perrigo Co. in April 3, 2013. Reason: Subpotent; 12 month time point for the active ingredient Phenylephrine HCl.. Check the official notice for the remedy. Verify recall #D-216-2013 with the FDA Drug before acting.
The recall
L. Perrigo Co. issued this low-severity FDA Drug recall-Subpotent; 12 month time point for the active ingredient Phenylephrine HCl..
Sourced from official FDA Drug enforcement records. Verify recall #D-216-2013 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-216-2013) was formally reported on April 3, 2013, with the manufacturer initiating the action on February 18, 2013. It is classified under Low severity (Class III), with a current status of Terminated. L. Perrigo Co. is listed as the recalling firm, operating out of Allegan, MI. Federal records list the affected scope as 60,048 Blister packs.
The documented reason for this recall is: Subpotent; 12 month time point for the active ingredient Phenylephrine HCl. Distribution data in the federal record shows the product reached: Walmart Distribution Center in Bentonville, AR. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
60,048 Blister packs
Related Recalls
6
5 from same agency
PE Daytime Cold/Flu LiqGel, Multi Symptom Relief, Acetaminophen/Dextromethorphan HBr/Phenylephrine HCL 325/10/5 mg gel caps 20 count blister pack, Distributed By: Wal-Mat Stores Inc., Bentonville, AR, 72716
Subpotent; 12 month time point for the active ingredient Phenylephrine HCl.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-216-2013 |
| Date reported | April 3, 2013 |
| Date initiated | February 18, 2013 |
| Recalling firm | L. Perrigo Co. |
| Firm location | Allegan, MI |
| Affected scope | 60,048 Blister packs |
| Distribution | Walmart Distribution Center in Bentonville, AR |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported April 3, 2013. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.